The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6555-6564
Author(s):
Tanja Matijevic Glavan and Jasminka Pavelic
Attacking c-Myc: Targeted and Combined Therapies for Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6543-6554
Author(s):
Huilin Huang, Hengyou Weng, Hui Zhou and Lianghu Qu
Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6529-6542
Author(s):
Lidija Milkovic, Werner Siems, Renate Siems and Neven Zarkovic
Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6513-6521
Author(s):
Cristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano and Ramon Alemany
Tankyrase Inhibitors as Therapeutic Targets for Cancer
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
1967-1976
Author(s):
Ahmed Kamal, Sd. Riyaz, Ajay Kumar Srivastava and Abdul Rahim
Resveratrol and Stroke: from Chemistry to Medicine
Journal:
Current Neurovascular Research
Volume:
11
Page:
390-397
Author(s):
Seyed Fazel Nabavi, Huige Li, Maria Daglia and Seyed Mohammad Nabavi
Recent Advances in the Structure-Based and Ligand-Based Design of IKKβ Inhibitors as Anti-inflammation and Anti-cancer Agents
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
3893-3917
Author(s):
Jing-Jie Huang, Hong-Xi Chu, Zheng-Yu Jiang, Xiao-Jin Zhang, Hao-Peng Sun and Qi-Dong You
A Discussion of MicroRNAs in Cancers
Journal:
Current Bioinformatics
Volume:
9
Page:
453-462
Author(s):
Shi Hua, Wu Yun, Zeng Zhiqiang and Quan Zou
Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6472-6488
Author(s):
Teemu Haikarainen, Stefan Krauss and Lari Lehtio
Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6361-6374
Author(s):
Roger R. Reddel